Clinical Trials Directory

Trials / Completed

CompletedNCT06642922

Gross Motor Abnormalities in Relation to Balance and Weight Indicators in Diplegia

Correlation Between BMI , Balance and Gross Motor Capacities in Children with Spastic Diplegia

Status
Completed
Phase
Study type
Observational
Enrollment
104 (actual)
Sponsor
Lamis Neyazy Elrakhawy · Academic / Other
Sex
All
Age
5 Years – 10 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to investigate the correlation between BMI and balance and gross motor capacities in children with spastic diplegia. The main question it aims to answer is: Is there a correlation between BMI, balance disturbances and gross motor capacity in children with spastic diplegic cerebral palsy? Researchers compared between results of biodex balance system , GMFM and BMI measures participants stood on biodex balance platform for balance measurement and performed Gross Motor Function Measurement items for gross motor capacities assessment

Detailed description

Spastic diplegia is the most common type of CP that results in problems with posture, balance, as well as gait control. For children suffering from spastic diplegic CP, balance problems provide a significant difficulty since they make it difficult for them to achieve and maintain balance . Additionally, they commonly demonstrate delayed development of gross motor function that has been connected to functional outcomes, such as daily living tasks . The prevalence of obesity in the CP population has risen over the last decade from 7.7 to 16.5 %. . Obesity is associated with health risks and difficulties in balance and walking. this cross-sectional-correlation study was conducted at the Outpatient Clinic at the Faculty of Physical Therapy, Cairo University. The study included 104 diplegic children aged from 5-10 years, 53 in normal weight group and 51 in overweight group. Dynamic balance was evaluated by overall stability index (OSI) in biodex balance system and gross motor capacities (GMC) were evaluated by standing \&walking dimensions in GMFM

Conditions

Timeline

Start date
2022-10-20
Primary completion
2023-06-15
Completion
2023-07-12
First posted
2024-10-15
Last updated
2024-10-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06642922. Inclusion in this directory is not an endorsement.